
Acerca de
Program
COMING SOON
9.30-9.35 Welcome & introduction (H.L.A. Janssen)
NASH (Chair tbc)
09.35-9.50 NASH & Fibrosis screening in the population based setting – Willem Pieter Brouwer
9.50-10.10 Holistic approach for the treatment of patients with NASH – Liesbeth van Rossum
10.10-10.20 Interactive table discussion
State of the Art Lecture
10.20-10.50 Acute kidney injury & fluid/salt balances in liver disease - Ewout Hoorn
10.50-11.20 Break
Liver Transplantation (Chair tbc)
11.20-11.35 Referral for liver transplantation with a low MELD score? – Caroline den Hoed
11.35-11.55 Working around the MELD: Living-related donation liver transplantation – Robert Porte
11.55-12.20 Graft preservation and regenerative medicine – Vincent de Meijer
12.20-12.30 Interactive table discussion
12.30-13.30 Lunch
State of the Art
13.30-13.35 Solko W. Schalm Award Ceremony
13.35-14.05 HBV/HDV: present and future – Heiner Wedemeyer
Liver tumors (Chair tbc)
14.05-14.20 How to optimize HCC surveillance in chronic HBV infection – yes or no? – Milan Sonneveld
14.20-14.45 TIPS before advanced therapies for HCC – Dominique Thabut
14.45-15.10 New treatment schemes for HCC: From immunotherapy to Yttrium – Maria Reig
15.10-15.20 Interactive table discussion
State of the Art
15.20-15.50 Difficult to treat AIH – Treatment roadmap, off-label therapies and response criteria - Christoph Schramm
15.50-16.00 Closing remarks – Harry Janssen
16.35 Drinks